Primary Open Angle Glaucoma
Conditions
Keywords
adherence, glaucoma, motivational interviewing
Brief summary
The investigators are studying motivational interviewing (MI). MI is a counseling method to help people adopt healthy behaviors. The investigators will test whether MI improves patients' accurate use of glaucoma eye drops. The investigators will train eye clinic staff called glaucoma educators to use MI. Up to 250 patients at 3 clinics will be recruited. All patients will receive their usual eye care. Based on chance, some patients will also be supported by a glaucoma educator. The groups will be compared on medication adherence using micro-electro-mechanical system(MEMS). MEMS are electronic bottle caps that track when a medication bottle is opened. Patients will be aware that their medication use is tracked. The groups will also be compared on treatment value, outcomes, and cost. The investigators will also collect data on variables that may predict medication adherence.
Interventions
BEHAVIORALmotivational interviewing
counseling intervention
BEHAVIORALthree phone calls to remind patients to take their eye drops
reminder phone calls
Sponsors
Merck Sharp & Dohme LLC
University of Colorado, Denver
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Caregiver)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* community-dwelling adults with primary or secondary open-angle glaucoma, and * a current prescription for monotherapy topical glaucoma medication.
Exclusion criteria
* patient-reported inability to administer eye drops that cannot be addressed successfully through in-person instruction at the clinic, * cognitive impairment at a level that would in the judgment of the referring physician interfere with study participation, * referring physician's determination that glaucoma surgery is likely within the next 6 months, * any active medical, psychological, or substance use disorder that would in the referring physician's judgment significantly interfere with study participation (e.g., comorbid congestive heart failure (CHF) resulting in a recent hospitalization; active psychosis due to uncontrolled bipolar disorder; etc.), or * no visual field test within the past 6 months (data required for the randomization approach described below).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Primary Outcomes - MEMS-based Medication Adherence and Persistence: | 1 month | Compare adherence and persistence between the intervention and control groups. (Medication Event Monitoring Systems)that record the date and time a pill bottle is opened we are evaluating the percentage of prescribed doses taken during ain one-week intervals, but will augment it by also considering a more fine-grained percentage of prescribed doses taken in required dosing window (defined as within 3 hours before or after the scheduled time) as a second primary outcome measure. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Counselor-Rated Medication Adherence | 1 Month | we will supplement MEMS-based adherence metrics with a counselor rating of adherence completed by the glaucoma educator during each in-person or telephone contact with intervention group participants. The interview also measures patients' perceived reasons for nonadherence, including treatment cost, lack of commitment based on low perceived benefits of treatment, and fear of potential adverse drug events (ADEs) |
Countries
United States
Outcome results
None listed